SCHEMBL7705320

SCHEMBL7705320

COc1ccc(-c2ccc3cc(OC)ccc3c2Oc2ccc(O)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 11/20 0.53
ESR1 P03372 10/20 0.53
LTA4H P09960 1/20 0.49
XDH P47989 1/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
NOD2 Q9HC29 1/20 0.44
NPC1 O15118 1/20 0.44
MIF P14174 1/20 0.44
RAB9A P51151 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
SIRT3 Q9NTG7 1/20 0.44
ERAP1 Q9NZ08 1/20 0.44
ESRRA P11474 1/20 0.43
ABL1 P00519 1/20 0.43
ABCB1 P08183 1/20 0.43
BCR P11274 1/20 0.43
TP53 P04637 2/20 0.43
MAPT P10636 2/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6050136 0.88 ESR1 (0.50) ESR2ESR1LTA4HMEN1KMT2A
SCHEMBL30494152 0.88 ESR1 (0.60) ESR2ESR1XDH
SCHEMBL3111436 0.88 ESR1 (0.60) ESR2ESR1XDH
SCHEMBL7934940 0.86 SMN1; SMN2 (0.45) ESR2ESR1MEN1KMT2ANPC1
SCHEMBL8501462 0.86 ESR1 (0.47) ESR2ESR1XDHMEN1KMT2A
SCHEMBL4966110 0.86 MGAM (0.53) ESR2ESR1NOD2MAPTMAPK1
SCHEMBL8501466 0.85 AKR1C3 (0.55) ESR2ESR1MAPTTSHRCYP3A4
SCHEMBL7187874 0.84 ESR1 (0.55) ESR2ESR1NPC1RAB9ATP53
SCHEMBL1359376 0.84 ESR1 (0.59) ESR2ESR1MIFMAPK1KDM4E
SCHEMBL7189743 0.83 ALDH1A1 (0.49) ESR2ESR1MAPTHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355632-B1 AROMATIC ETHER AMINES FOR TREATMENT OF OSTEOPOROSIS ELI LILLY AND COMPANY 2002-03-12 US disclosed
US-6268361-B1 ESTROGEN DEPENDENT DISORDERS INCLUDING CANCER, ENODMETRIOSIS, ETC PALKOWITZ ALAN D (US) 2001-07-31 US disclosed
US-5998401-A POSTMENOPAUSE THERAPY ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
EP-0729951-B1 Naphthyl compounds, intermediates, compositions, and methods LILLY CO ELI (US) 1999-06-02 EP disclosed
US-5574190-A AROMATIC ETHER DERIVATIVES FOR TREATMENT OF HORMONE DEPENDENT CANCER SUCH AS BREAST CANCER ELI LILLY AND COMPANY (US) 1996-11-12 US disclosed
US-5567712-A THERAPY FOR ENDOMETRIOSIS ELI LILLY AND COMPANY (US) 1996-10-22 US disclosed
EP-0729951-A1 Naphthyl compounds, intermediates, compositions, and methods ELI LILLY AND COMPANY (US) 1996-09-04 EP disclosed